These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11345481)

  • 21. Is serum copper a "trait marker" of unipolar depression? A preliminary clinical study.
    Schlegel-Zawadzka M; Zieba A; Dudek D; Zak-Knapik J; Nowak G
    Pol J Pharmacol; 1999; 51(6):535-8. PubMed ID: 10817533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Debrisoquine hydroxylation phenotypes of patients with high versus low to normal serum antidepressant concentrations.
    Tacke U; Leinonen E; Lillsunde P; Seppälä T; Arvela P; Pelkonen O; Ylitalo P
    J Clin Psychopharmacol; 1992 Aug; 12(4):262-7. PubMed ID: 1527229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic monitoring of antidepressant drugs: current methodology and applications.
    Orsulak PJ
    J Clin Psychiatry; 1986 Oct; 47 Suppl():39-52. PubMed ID: 3531191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of clinical and psychological methods in estimating antidepressants efficacy in treatment of depression (preliminary report)].
    Puzyński S; Koszewska I; Habrat E; Fornal S; Bzinkowska D; Gradzka D; Kalinowski A; Swiecicki Ł; Torbiński J
    Psychiatr Pol; 2002; 36(2):225-38. PubMed ID: 12043041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High blood concentrations of imipramine or clomipramine and therapeutic failure: a case report study using drug monitoring data.
    Balant-Gorgia AE; Balant LP; Garrone G
    Ther Drug Monit; 1989; 11(4):415-20. PubMed ID: 2741190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cation fluxes in erythrocytes of patients with endogenous depression in the course of treatment with antidepressant drugs.
    Rybakowski J; Potok E; Strzyzewski W; Markowski S
    Pol J Pharmacol Pharm; 1982; 34(5-6):295-301. PubMed ID: 7187045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
    Politis AM; Papadimitriou GN; Theleritis CG; Psarros C; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1227-30. PubMed ID: 18442877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appropriateness of therapeutic drug monitoring for lithium.
    Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
    J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
    J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine.
    Dasgupta A; Wells A; Datta P
    Ther Drug Monit; 2007 Feb; 29(1):134-9. PubMed ID: 17333576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Baghai TC; Marcuse A; Brosch M; Schüle C; Eser D; Nothdurfter C; Steng Y; Noack I; Pietschmann K; Möller HJ; Rupprecht R
    World J Biol Psychiatry; 2006; 7(2):82-90. PubMed ID: 16684680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.
    Mbaya P
    Hum Psychopharmacol; 2002 Oct; 17(7):335-9. PubMed ID: 12415551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.